GENEVENTIV THERAPEUTICS INC
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.5Mattributed |
|---|---|
| Latest round | grant, $2.5M, 2024-01-01attributed |
| Founded | unknown |
| Headquarters | RALEIGH, North Carolina |
| Industry | unknown |
| Stage | unknown |
| Website | geneventiv.com |
Development of a universal gene therapy for hemophilia A or B with or without inhibitors
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | grant | $2.5M | undisclosed |
Detected tech stack
WordPress, Apache HTTP Server, Yoast SEO 27.6, Google Analytics, Google Tag Manager, Gravity Forms 2.10.2, jQuery Migrate 3.4.1, PHP, DoubleClick Floodlight, WP Rocket 3.21.3, MySQL, jquery 3.7.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.5M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $2.5M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | geneventiv.com, read 2026-05-02 |
| Description | self-reported | geneventiv.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.